Clinical outcomes in idursulfase-treated patients with mucopolysaccharidosis type II: 3-year data from the hunter outcome survey (HOS)

Survival in idursulfase-treated and untreated patients with mucopolysaccharidosis type II: data from the Hunter Outcome Survey (HOS)

(2017) Barbara K. Burton et al.   JOURNAL OF INHERITED METABOLIC DISEASE

Ten years of the Hunter Outcome Survey (HOS): insights, achievements, and lessons learned from a global patient registry

(2017) Joseph Muenzer et al.   Orphanet Journal of Rare Diseases

Clinical response to long term enzyme replacement treatment in children, adolescent and adult patients with Hunter syndrome

(2015) Jaime Dalmau Serra et al.   MEDICINA CLINICA

Diagnosis, quality of life, and treatment of patients with Hunter syndrome in the French healthcare system: a retrospective observational study

(2015) Nathalie Guffon et al.   Orphanet Journal of Rare Diseases

Clinical efficacy of Enzyme Replacement Therapy in paediatric Hunter patients, an independent study of 3.5 years

(2014) Rosella Tomanin et al.   Orphanet Journal of Rare Diseases

A multicenter, open-label study evaluating safety and clinical outcomes in children (1.4–7.5 years) with Hunter syndrome receiving idursulfase enzyme replacement therapy

(2013) Roberto Giugliani et al.   GENETICS IN MEDICINE

Clinical and Ultrasonographic Measurement of Liver Size in Normal Children

(2013) Puja Amatya et al.   INDIAN JOURNAL OF PEDIATRICS

The effect of idursulfase on growth in patients with Hunter syndrome: Data from the Hunter Outcome Survey (HOS)

(2013) Simon A. Jones et al.   MOLECULAR GENETICS AND METABOLISM

The relationship between anti-idursulfase antibody status and safety and efficacy outcomes in attenuated mucopolysaccharidosis II patients aged 5years and older treated with intravenous idursulfase

(2013) A.J. Barbier et al.   MOLECULAR GENETICS AND METABOLISM

Early initiation of enzyme replacement therapy for the mucopolysaccharidoses

(2013) Joseph Muenzer   MOLECULAR GENETICS AND METABOLISM

Enzyme replacement therapy for mucopolysaccharidosis II from 3 months of age: a 3-year follow-up

(2011) A Tylki- Szymanska et al.   ACTA PAEDIATRICA

Idursulfase treatment of Hunter syndrome in children younger than 6 years: Results from the Hunter Outcome Survey

(2011) Joseph Muenzer et al.   GENETICS IN MEDICINE

Hearing loss in patients with mucopolysaccharidosis II: Data from HOS – the Hunter Outcome Survey

(2011) Annerose Keilmann et al.   JOURNAL OF INHERITED METABOLIC DISEASE

Cardiac disease in patients with mucopolysaccharidosis: presentation, diagnosis and management

(2011) Elizabeth A. Braunlin et al.   JOURNAL OF INHERITED METABOLIC DISEASE

Prevalence and Characterization of Cardiac Involvement in Hunter Syndrome

(2011) Christoph Kampmann et al.   JOURNAL OF PEDIATRICS

Incidence and timing of infusion-related reactions in patients with mucopolysaccharidosis type II (Hunter syndrome) on idursulfase therapy in the real-world setting: A perspective from the Hunter Outcome Survey (HOS)

(2011) Barbara K. Burton et al.   MOLECULAR GENETICS AND METABOLISM

Therapy for the mucopolysaccharidoses

(2011) V. Valayannopoulos et al.   RHEUMATOLOGY

Importance of surgical history in diagnosing mucopolysaccharidosis type II (Hunter syndrome): Data from the Hunter Outcome Survey

(2010) Nancy J. Mendelsohn et al.   GENETICS IN MEDICINE

Long-term, open-labeled extension study of idursulfase in the treatment of Hunter syndrome

(2010) Joseph Muenzer et al.   GENETICS IN MEDICINE

Home treatment with intravenous enzyme replacement therapy with idursulfase for mucopolysaccharidosis type II — data from the Hunter Outcome Survey

(2010) Barbara K. Burton et al.   MOLECULAR GENETICS AND METABOLISM

Initial report from the Hunter Outcome Survey

(2009) J Edmond Wraith et al.   GENETICS IN MEDICINE

Mortality and cause of death in mucopolysaccharidosis type II—a historical review based on data from the Hunter Outcome Survey (HOS)

(2009) S. A. Jones et al.   JOURNAL OF INHERITED METABOLIC DISEASE

Japan Elaprase® Treatment (JET) study: Idursulfase enzyme replacement therapy in adult patients with attenuated Hunter syndrome (Mucopolysaccharidosis II, MPS II)

(2009) Torayuki Okuyama et al.   MOLECULAR GENETICS AND METABOLISM

Multidisciplinary Management of Hunter Syndrome

(2009) J. Muenzer et al.   PEDIATRICS